Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

Clinical trial NCT05204563 · COMPLETED

Trial details

NCT number: NCT05204563
Sponsor: Evopoint Biosciences Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

Start date: 2022-07-31
Primary completion: 2024-09-29
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.